Magnetic Resonance Imaging (MRI) Efficacy of Ofatumumab in Relapsing-Remitting Multiple Sclerosis - Results of a Phase II Study

被引：0
|
作者：
Sorensen, Per
Drulovic, Jelena
Havrdova, Eva
Lisby, Steen
Derosier, Frederick
Shackelford, Steve
Filippi, Massimo
机构：
来源：
NEUROLOGY | 2011年 / 76卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A85 / A85
页数：1
相关论文
共 50 条
  • [31] Magnetic Resonance Imaging (MRI) Outcomes in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS) Treated with Cladribine Tablets: Results from the 120-Week Phase IIIb Extension of the CLARITY Study
    Giancarlo, Comi
    Ciovannoni, Gavin
    Cook, Stuart
    Rammohan, Kottil
    Soelberg-Soerensenn, Per
    Vermersch, Patrick
    Martin, Emily
    Dangond, Fernando
    Rieckmann, Peter
    NEUROLOGY, 2016, 86
  • [32] MRI AND COGNITIVE PATTERNS IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS
    PUGNETTI, L
    MENDOZZI, L
    MOTTA, A
    CATTANEO, A
    BISERNI, P
    CAPUTO, D
    CAZZULLO, CL
    VALSECCHI, F
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1993, 115 : S59 - S65
  • [33] Subtyping relapsing-remitting multiple sclerosis using structural MRI
    Zhuo, Zhizheng
    Li, Yongmei
    Duan, Yunyun
    Cao, Guanmei
    Zheng, Fenglian
    Ding, Jinli
    Tian, Decai
    Wang, Xinli
    Wang, Jinhui
    Zhang, Xinghu
    Li, Kuncheng
    Zhou, Fuqing
    Huang, Muhua
    Li, Yuxin
    Li, Haiqing
    Zeng, Chun
    Zhang, Ningnannan
    Sun, Jie
    Yu, Chunshui
    Han, Xuemei
    Haller, Sven
    Barkhof, Frederik
    Shi, Fudong
    Liu, Yaou
    JOURNAL OF NEUROLOGY, 2021, 268 (05) : 1808 - 1817
  • [34] Oral ponesimod in relapsing-remitting multiple sclerosis: a randomised phase II trial
    Olsson, Tomas
    Boster, Aaron
    Fernandez, Oscar
    Freedman, Mark S.
    Pozzilli, Carlo
    Bach, Doris
    Berkani, Ouali
    Mueller, Markus S.
    Sidorenko, Tatiana
    Radue, Ernst-Wilhelm
    Melanson, Maria
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 (11): : 1198 - 1208
  • [35] Efficacy and safety of ocrelizumab in patients with relapsing-remitting multiple sclerosis: week 96 results of a phase II, randomised, multicentre trial
    Kappos, L.
    Li, D.
    Calabresi, P.
    O'Connor, P.
    Bar-Or, A.
    Barkhof, F.
    Yin, M.
    Leppert, D.
    Glanzmann, R.
    Tinbergen, J.
    Hauser, S. L.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S194 - S195
  • [36] Cost-consequence analysis of ofatumumab for the treatment of relapsing-remitting multiple sclerosis in Canada
    Bhan, Virender
    Clift, Fraser
    Baharnoori, Moogeh
    Thomas, Kimberly
    Patel, Barkha P.
    Blanchette, Francois
    Adlard, Nicholas
    Vudumula, Umakanth
    Gudala, Kapil
    Dutta, Nikkita
    Grima, Daniel
    Mouallif, Soukaina
    Farhane, Fatine
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2023, 12 (09)
  • [37] Magnetic resonance imaging results from the first year of the ADVANCE study, a pivotal phase 3 trial of peginterferon β-1a in patients with relapsing-remitting multiple sclerosis
    Arnold, D.
    Calabresi, P.
    Kieseier, B.
    Zhu, Y.
    Liu, S.
    Hung, S.
    Deykin, A.
    Sheikh, S.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 452 - 453
  • [38] Cost-Effectiveness Analysis of Ofatumumab for the Treatment of Relapsing-Remitting Multiple Sclerosis in Canada
    Moogeh Baharnoori
    Virender Bhan
    Fraser Clift
    Kimberly Thomas
    Soukaïna Mouallif
    Nicholas Adlard
    Philip Cooney
    François Blanchette
    Barkha P. Patel
    Daniel Grima
    PharmacoEconomics - Open, 2022, 6 : 859 - 870
  • [39] Cost-Effectiveness Analysis of Ofatumumab for the Treatment of Relapsing-Remitting Multiple Sclerosis in Canada
    Baharnoori, Moogeh
    Bhan, Virender
    Clift, Fraser
    Thomas, Kimberly
    Mouallif, Soukaina
    Adlard, Nicholas
    Cooney, Philip
    Blanchette, Francois
    Patel, Barkha P.
    Grima, Daniel
    PHARMACOECONOMICS-OPEN, 2022, 6 (06) : 859 - 870
  • [40] Safety and tolerability of BG-12 in patients with relapsing-remitting multiple sclerosis: results from the phase 3 CONFIRM (Comparator and an Oral Fumarate in Relapsing-Remitting Multiple Sclerosis) study
    Havrdova, E.
    Phillips, J. T.
    Fox, R. J.
    Miller, D.
    Kita, M.
    Hutchinson, M.
    Raghupathi, K.
    Yuan, H.
    Novas, M.
    Sweetser, M. T.
    Viglietta, V.
    Dawson, K. T.
    JOURNAL OF NEUROLOGY, 2012, 259 : S105 - S105
12345